Overview

Pharmacokinetic Study of Fentanyl 400 µg Sublingual Spray, Actiq® 400 µg Transmucosally, and Fentanyl Citrate Injection 100 µg Intravenously (iv)

Status:
Completed

Trial end date:
2007-05-01

Target enrollment:

Participant gender:

Summary

The objective of this study was to compare the rate of absorption and bioavailability of fentanyl 400 µg sublingual spray, Actiq® 400 µg transmucosally, and fentanyl citrate injection 100 µg intravenously.

Phase:

Phase 1

Details

Lead Sponsor:

INSYS Therapeutics Inc

Treatments:

Citric Acid
Fentanyl
Naltrexone
Sodium Citrate